ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New

Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report

FDA-approved medications for OUD, with typical dosing paradigms for

Assessing and Treating Opioid Use Disorder in Pregnancy

10-K

Thursday, November 16, 2023 - KFF Health News

PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment, Addiction Science & Clinical Practice

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD) - 뉴스와이어

TESCREAL hallucinations: Psychedelic and AI hype as inequality engines in: Journal of Psychedelic StudiesOnline First

ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)

The Opioid Crisis and Recent Federal Policy Responses